Molecular Docking Studies and ADME Prediction of Benzimidazole Derivatives on Anti-convulsant Activity by Inhibiting Voltage-Gated Sodium Channel (NavMs)-5HVX

ABSTRACT

Background: Epilepsy was described as utmost common be habitual brain complaint. A typical symptom of epilepsy is unbridled storms due to transient neuronal discharges. Despite the fact that numerous novel anti-convulsants have been developed in the Indian request but after treatment of new and current curatives; certain kinds of seizures are still not sufficiently controlled by smaller side goods. Materials and Methods: The exploration reported on concentrated work on molecular docking and ADME of the relations that do between the chlorinated benzimidazole derivations and the sodium (Nav) voltage-gated channels. A series of the benzimidazole derivations were planned and studied in silico was performed by through a sodium channel inhibitor GABAergic pathway. The medicine- likeness parcels of the designed composites were prognosticated. Results: All the designed composites showed good in silico ADME and molecular docking parcels and delved for Voltage-gated Sodium Channel (NavMs)-5HVX inhibitory exertion. According to molecular docking studies, all composites showed better commerce with target protein and could be the potent asset of sodium channels via a GABAergic pathway. The designed benzimidazole derivations analogues may be more effective anticonvulsant drugs that are also safer. Conclusion: Voltage-gated Sodium Channel (NavMs)-5HVX is one of the crucial enzymes of GABAergic pathway biosynthesis in different natural fiefdoms and is set up in beast and also in humans. Voltage-gated Sodium Channel (NavMs)-5HVX proteins belong to the class of superfamily. It's the most conserved protein. Unlike other enzymes, Voltage-gated Sodium Channel (NavMs)-5HVX also gives strong particularity.

KEYWORDS

• Voltage-Gated Sodium Channels
• Molecular Docking
• Anticonvulsant
• Structure-Based Drug Design
• 3D QSAR

Showing references and in-text citations exactly as published.

• DOI10.5530/ijpi.13.4.108Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPI.

• Article · VOLUME 13, ISSUE 4Formulation and Comparison of Topical Dosage Forms Containing P-Herbo Extract for Acne TherapyN. Raghavendra Naveen, Keerthiraj KS, Gaganashree G, Prajitha Biju, Annegowda H V, Sindhoor S M · pp. 747–753Original ArticleSame type: Article
• Article · VOLUME 13, ISSUE 4Development and Optimization of Candesartan Cilexetil Loaded Solid Lipid NanoparticlesKrithiga Venkatesan, Gouranga Dutta, Damodharan Narayanaswamy, Abimanyu Sugumaran · pp. 754–762Original ArticleSame type: Article
• Article · VOLUME 13, ISSUE 4Formulation and Evaluation of Propranolol Hydrochloride Sustained Release Matrix Tablets Using Different Grades of HPMC and MCCPiyali Khamkat, Vivek Barik, Bhakti Bhusan Barik, Aritra Chakraborty, Dipsikha Patra, Prasenjit Mondal, Snigdha Chatterjee · pp. 763–771Original ArticleSame type: Article
• Article · VOLUME 13, ISSUE 4Development of Albumin Coated Nanoparticulate Capecitabine SuppositoriesMythili Gopalakrishnan, Subramanian Somaskanthan · pp. 772–777Original ArticleSame type: Article